In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Cg Oncology Inc (NASDAQ: CGON) closed at $20.11 in the last session, up 0.25% from day before closing price of $20.06. In other words, the price has increased by $0.25 from its previous closing price. On the day, 0.84 million shares were traded. CGON stock price reached its highest trading level at $20.634 during the session, while it also had its lowest trading level at $19.67.
Ratios:
We take a closer look at CGON’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 35.30 and its Current Ratio is at 35.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.RBC Capital Mkts initiated its Outperform rating on September 23, 2024, with a $66 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when POST LEONARD E sold 1,000 shares for $28.00 per share. The transaction valued at 28,000 led to the insider holds 0 shares of the business.
LEONARD E POST bought 4,000 shares of CGON for $111,200 on Mar 17 ’25. On Feb 18 ’25, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.61 each. As a result, the insider received 28,610 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 1532721792 and an Enterprise Value of 790960960. For the stock, the TTM Price-to-Sale (P/S) ratio is 1344.49 while its Price-to-Book (P/B) ratio in mrq is 2.09. Its current Enterprise Value per Revenue stands at 694.435 whereas that against EBITDA is -6.9.
Stock Price History:
The Beta on a monthly basis for CGON is 1.48, which has changed by -0.44767922 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $46.99, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is -20.68%, while the 200-Day Moving Average is calculated to be -36.76%.
Shares Statistics:
According to the various share statistics, CGON traded on average about 813.25K shares per day over the past 3-months and 1703240 shares per day over the past 10 days. A total of 76.15M shares are outstanding, with a floating share count of 46.04M. Insiders hold about 39.60% of the company’s shares, while institutions hold 67.14% stake in the company. Shares short for CGON as of 1743379200 were 8048175 with a Short Ratio of 9.90, compared to 1740700800 on 6999756. Therefore, it implies a Short% of Shares Outstanding of 8048175 and a Short% of Float of 10.65.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
